Galmed Pharmaceuticals
(NASDAQ:GLMD)
$0.367
-0.0091[-2.42%]
At close: Apr 15
$0.367
0[0.00%]
PreMarket: 6:40PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Galmed Pharmaceuticals Stock (NASDAQ:GLMD), Quotes and News Summary

Galmed Pharmaceuticals Stock (NASDAQ: GLMD) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 213.095K
Day Range- - -
52 Wk Range0.260 - 7.800
Market Cap$2.206M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
51
Short Interest
0.68%
Days to Cover1

Recent News

Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter.
Avi Kapoor
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on Monday.
Avi Kapoor
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEXLETOL® tablets in diverse populations.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
2.8
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commerc...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
GLMD

FAQ

Q

How do I buy Galmed Pharmaceuticals (GLMD) stock?

A

You can purchase shares of Galmed Pharmaceuticals (NASDAQ: GLMD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Galmed Pharmaceuticals's (GLMD) competitors?

A

There are no as such competitors for Galmed Pharmaceuticals.

Q

What is the target price for Galmed Pharmaceuticals (GLMD) stock?

A

The latest price target for Galmed Pharmaceuticals (NASDAQ: GLMD) was reported by Maxim Group on Monday, July 24, 2023. The analyst firm set a price target for 4.00 expecting GLMD to rise to within 12 months (a possible 989.92% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Galmed Pharmaceuticals (GLMD)?

A

The stock price for Galmed Pharmaceuticals (NASDAQ: GLMD) is $0.367 last updated April 15, 2024 at 6:40 PM EDT.

Q

Does Galmed Pharmaceuticals (GLMD) pay a dividend?

A

There are no upcoming dividends for Galmed Pharmaceuticals.

Q

When is Galmed Pharmaceuticals (NASDAQ:GLMD) reporting earnings?

A

Galmed Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 30, 2024.

Q

Is Galmed Pharmaceuticals (GLMD) going to split?

A

There is no upcoming split for Galmed Pharmaceuticals.

Q

What sector and industry does Galmed Pharmaceuticals (GLMD) operate in?

A

Galmed Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.